Dr Rick Morton
Executive Leader And Board Chairman
Little Milton
Summary
Global pharmaceutical executive and board-level leader with over 25 years of cross-functional experience in biopharma, strategic consulting, and healthcare governance. Deep expertise in market access, HTA, HEOR, and medical affairs, with a proven track record of launching innovative therapies and driving commercial success across rare diseases, neurology, immunology, and oncology. Recognized for building high-performing international teams, influencing policy-level stakeholders, and advising early-to-late-stage biotech firms on maximizing asset value. Adept at integrating science, strategy, and commercial operations to achieve high value outcomes. Organized and dependable candidate successful at managing multiple priorities with a positive attitude. Willingness to take on added responsibilities to meet team goals. Innovative technology professional with several years of diverse experience. Skilled in enhancing systems and aligning technical solutions with business objectives. Proven success in leading projects from start to finish and contributing to organizational growth and success. Demonstrates strong analytical, communication, and teamwork skills, with proven ability to quickly adapt to new environments. Eager to contribute to team success and further develop professional skills. Brings positive attitude and commitment to continuous learning and growth. Results-oriented achiever with proven ability to exceed targets and drive success in fast-paced environments. Combines strategic thinking with hands-on experience to deliver impactful solutions and enhance organizational performance.
Overview
31
31
years of professional experience
1981
1981
years of post-secondary education
3
3
Languages
Work History
Head of Europe, Commercial, Value, Access & HTA
Neurocrine Biosciences
London, England
09.2023 - Current
- Leading EU market access, HTA, and pricing strategy for rare disease and neuroscience pipeline assets
- Leadership of European commercial business
- Providing strategic input into clinical development programs and real-world evidence design
- Excellent communication skills, both verbal and written.
- Overseeing the creation of legal entities and hiring for Access, Medical Affairs, and Commercial teams across Europe
- Driving HTA planning and U.K and EU-level scientific engagement for pipeline assets ans indications (CAH)
Chairman
Biotherapy Services Ltd
London, England
05.2023 - Current
- Chairing board meetings and advising executive leadership on governance, strategic direction, investor and shareholder partnerships and securing investment.
Chief Medical Affairs Officer / Global Head of Access
WPP (VML)
London, England
06.2018 - 07.2023
- Founded and led a global medical strategy unit delivering cross-functional consulting to medical devices and biopharma clients
- Led WG Access consulting division in Shanghai, London, and New York to deliver global and domestic market access solutions
- Led expansion to new medical science consulting hub in Manchester
- Designed and implemented strategic frameworks for value creation, indication sequencing, and stakeholder engagement
- Oversaw global Patient Engagement partnerships and co-led collaborations with ESPCH (European Society for Person Centered Healthcare)
Non-Executive Director
Biotherapy Services Ltd
Windsor, Windsor and Maidenhead
10.2018 - 04.2023
- Provided board-level oversight and strategic input on clinical development and commercial planning for regenerative medicine
International Head, Value & Access
Allergan International
Marlow, Buckinghamshire
06.2017 - 03.2018
- Directed ex-US market access, value development, and HEOR strategy across multiple therapeutic areas
- Participated in global governance teams and integration planning for company acquisitions
Associate VP, International Pricing & Market Access
Allergan (UK)
Marlow, Buckinghamshire
03.2015 - 05.2017
- Led international market access and pricing strategy across 10 global regions
- Supported Allergan-Pfizer deal preparations; led policy development for commercial pricing
Head of HEOR, Pricing & Reimbursement, EMEA
Allergan (UK)
04.2013 - 02.2015
- Managed regional HEOR and pricing functions across EMEA
- Ensured regional HTA alignment with global clinical and commercial strategy
Global Director, Market Access
Novartis Pharma
Basel , Switzerland
03.2012 - 10.2012
- Company Overview: (Basel)
- Created global payer strategy for multiple pipeline assets
- Defined evidence-generation frameworks for phase IIb–IV clinical trials
- (Basel)
VP / Senior Director, Consulting
PAREXEL International
London, England
08.2009 - 03.2012
- Led global consulting teams focused on clinical-commercial strategy for biotech and pharma clients
Managing Director, WG Consulting
Grey Healthcare / WPP
High Wycombe, Buckinghamshire
03.2004 - 08.2009
- Delivered global access and value consulting for clients across neuroscience, oncology, vaccines, and cardiometabolic disease
District Manager
Pfizer UK
Edinburgh, Scotland
01.2002 - 01.2004
- Managed sales and hospital teams in Scotland and Ireland; coached talent into senior roles; engaged with HTA bodies
Regional Business Manager
Yamanouchi Pharmaceuticals
London, England
01.2000 - 01.2002
- Led regional sales and access efforts across Scotland and NI; represented pharma sector in HTBS policy groups
Earlier Roles
01.1994 - 01.2000
- Searle Pharmaceuticals, Inveresk Research, University of Wolverhampton, University of Manchester
- Spanned preclinical BD, medical liaison, HEOR, and academic leadership in physiology and neuropharmacology
Education
Ph.D. - Neuropharmacology
University of Manchester
B.Sc. (Hons) - Pharmacology
University of Liverpool
Executive Program - Strategic Leadership
Chicago Business School
Health Economics Certificate - undefined
Brunel University
TEFL Certification -
British Institutes
Firenze 06.2025 - 07.2012
Skills
- Board support in biotechnology
- Building collaborative partnerships
- Cross-functional team development
- Biotech R&D expertise
- Clinical study design
- Understanding of regulatory frameworks
- HTA framework expertise
- Team leadership expertise
- Interpersonal communication
- Expertise in global market access
- Health technology evaluation
- Global product launch strategy
- Early-stage development planning
- Utilization of real-world evidence integration
Voluntary
- Liveryman – Worshipful Society of Apothecaries
- Founder Liveryman – Company of Communicators
- Fellow - Royal Society of Medicine
Board And Leadership Roles
- Chairman, Biotherapy Services Ltd, 2023–Present
- Non-Executive Director, Biotherapy Services Ltd, 2018–2023
- EMEA Executive Committee, Medical Affairs Professional Society (MAPS), 2018–2019, Co-founder of regional body, payer evidence advisor
Technology And Tools
- Microsoft Office Suite
- PowerPoint
- HTA modelling platforms
- CRM systems
- Global access analytics tools
Affiliations
Liveryman - Worshipful Society of Apothecaries
Founder Liveryman - Company of Communicators
Fellow - Royal Society of Medicine
Timeline
TEFL Certification -
British Institutes
06.2025 - 07.2012
Head of Europe, Commercial, Value, Access & HTA
Neurocrine Biosciences
09.2023 - Current
Chairman
Biotherapy Services Ltd
05.2023 - Current
Non-Executive Director
Biotherapy Services Ltd
10.2018 - 04.2023
Chief Medical Affairs Officer / Global Head of Access
WPP (VML)
06.2018 - 07.2023
International Head, Value & Access
Allergan International
06.2017 - 03.2018
Associate VP, International Pricing & Market Access
Allergan (UK)
03.2015 - 05.2017
Head of HEOR, Pricing & Reimbursement, EMEA
Allergan (UK)
04.2013 - 02.2015
Global Director, Market Access
Novartis Pharma
03.2012 - 10.2012
VP / Senior Director, Consulting
PAREXEL International
08.2009 - 03.2012
Managing Director, WG Consulting
Grey Healthcare / WPP
03.2004 - 08.2009
District Manager
Pfizer UK
01.2002 - 01.2004
Regional Business Manager
Yamanouchi Pharmaceuticals
01.2000 - 01.2002
Earlier Roles
01.1994 - 01.2000
B.Sc. (Hons) - Pharmacology
University of Liverpool
Executive Program - Strategic Leadership
Chicago Business School
Health Economics Certificate - undefined
Brunel University
Ph.D. - Neuropharmacology
University of Manchester
Similar Profiles
Laico CookLaico Cook
Associate Director, Global Employee Benefit Programs at Neurocrine Biosciences, Inc.Associate Director, Global Employee Benefit Programs at Neurocrine Biosciences, Inc.
Tearsa GrayTearsa Gray
Psychiatry Account Specialist at Neurocrine BiosciencesPsychiatry Account Specialist at Neurocrine Biosciences
CHRISTIN CUDAHYCHRISTIN CUDAHY
Associate Scientist at Neurocrine BiosciencesAssociate Scientist at Neurocrine Biosciences
Seneha ManojSeneha Manoj
Online Legal assistant at Messrs Azim Kelvin Zaefri & AssociatesOnline Legal assistant at Messrs Azim Kelvin Zaefri & Associates
MATILDA ADJEI AMEYAWMATILDA ADJEI AMEYAW
Nursery supply staff at Evolve within recruitmentNursery supply staff at Evolve within recruitment